These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 14220146)

  • 1. [ON THE THERAPEUTIC USE OF EPSILON-AMINOCAPROIC ACID AND OTHER ANTIFIBRINOLYTICS].
    PERLICK E
    Dtsch Gesundheitsw; 1964 May; 19():900-3. PubMed ID: 14220146
    [No Abstract]   [Full Text] [Related]  

  • 2. [EFFECT OF EPSILON-AMINOCAPROIC ACID ON EXPERIMENTAL PANCREATITIS IN RATS].
    DIWOK K; GUELZOW M; TRETTIN HJ
    Z Gesamte Inn Med; 1965 Feb; 20():111-2. PubMed ID: 14264674
    [No Abstract]   [Full Text] [Related]  

  • 3. [ANTIPLASMIN ACTIVITY OF THE PANCREATIC TRYPSIN INHIBITOR AND OF EPSILON-AMINOCAPROIC ACID].
    DEBARBIERI A; SCEVOLA ME; FRANCHINI M
    Boll Chim Farm; 1964 Jan; 103():37-40. PubMed ID: 14131376
    [No Abstract]   [Full Text] [Related]  

  • 4. [FIBRINOLYSIS AND ANTIFIBRINOLYTIC THERAPY IN UROLOGIC OPERATIONS. EXAMINATIONS USING A NEW METHOD FOR MEASURING FIBRINOLYSIS].
    PIPER W; BUCHBERGER HG; SIMON S; KRUEGER J
    Med Welt; 1965 Feb; 8():385-96. PubMed ID: 14262868
    [No Abstract]   [Full Text] [Related]  

  • 5. [THE COMBINED EFFECT OF FIBRINOLYSIS INHIBITORS].
    MARKWARDT F; KLOECKING HP; RICHTER M
    Acta Biol Med Ger; 1964; 12():522-4. PubMed ID: 14134957
    [No Abstract]   [Full Text] [Related]  

  • 6. ON THE INTERACTION OF FIBRINOLYSIN (PLASMIN) WITH THE INHIBITORS ANTIFIBRINOLYSIN AND SOYBEAN TRYPSIN INHIBITOR.
    NANNINGA LB; GUEST MM
    Arch Biochem Biophys; 1964 Dec; 108():542-51. PubMed ID: 14244698
    [No Abstract]   [Full Text] [Related]  

  • 7. [INDICATIONS AND HANDLING OF FIBRINOLYTIC ENZYME INHIBITORS].
    BERNARD J; BOUSSER J; DREYFUS B; HAMBURGER J; PEQUIGNOT H
    Presse Med (1893); 1964 Jan; 72():167-9. PubMed ID: 14106785
    [No Abstract]   [Full Text] [Related]  

  • 8. [CLINICAL EXPERIENCES WITH EPSILON-AMINOCAPROIC ACID AS AN ANTIFIBRINOLYTIC AGENT IN VARIOUS OBSTETRICAL DISORDERS].
    PALACIO S; CANO A; YEPES E
    Rev Colomb Obstet Ginecol; 1964; 15():413-9. PubMed ID: 14258173
    [No Abstract]   [Full Text] [Related]  

  • 9. [HEMORRHAGIC SYNDROME IN LABOR].
    KAESER ; HALBERSTAADT
    Geburtshilfe Frauenheilkd; 1963 Nov; 23():1026. PubMed ID: 14112067
    [No Abstract]   [Full Text] [Related]  

  • 10. THE STABILITY OF FIBRINOLYTIC INHIBITORS IN HUMAN SERUM AND THE INHIBITOR CONTENT IN ANIMAL SERA.
    BLIX S
    Scand J Clin Lab Invest; 1964; 16():614-6. PubMed ID: 14224486
    [No Abstract]   [Full Text] [Related]  

  • 11. INHIBITION OF FIBRINOLYSIS AND FIBRINOGENOLYSIS IN MAN: COMPARISON OF EPILSON-AMINOCAPROIC AID AND KALLIKREIN INHIBITOR.
    BECK E; SCHMUTZLER R; DUCKERT F
    Thromb Diath Haemorrh; 1963 Nov; 10():106-19. PubMed ID: 14081273
    [No Abstract]   [Full Text] [Related]  

  • 12. [PRESENT TRENDS IN THE THERAPY OF HYPERFIBRINOLYTIC STATES].
    DETTORI AG; PONARI O
    Clin Ter; 1963 Oct; 27():97-114. PubMed ID: 14100829
    [No Abstract]   [Full Text] [Related]  

  • 13. EFFECT OF INHIBITORS OF FIBRINOLYTIC ENZYMES ON DEVELOPMENT OF PULMONARY METASTASES.
    CLIFFTON EE; AGOSTINO D
    J Natl Cancer Inst; 1964 Nov; 33():753-63. PubMed ID: 14231149
    [No Abstract]   [Full Text] [Related]  

  • 14. EPSILON-AMINOCAPROIC ACID AND OTHER INHIBITORS OF FIBRINOLYSIS.
    MCNICOL GP; DOUGLAS AS
    Br Med Bull; 1964 Sep; 20():233-9. PubMed ID: 14209764
    [No Abstract]   [Full Text] [Related]  

  • 15. [AN EFFECTIVE ANTIFIBRINOLYTIC AGENT: EPSILON-AMINOCAPROIC ACID].
    GROSSI F
    Clin Ter; 1963 Jul; 26():73-8. PubMed ID: 14050038
    [No Abstract]   [Full Text] [Related]  

  • 16. ACUTE FIBRINOLYTIC STATES IN SURGERY.
    MCNICOL GP; DOUGLAS AS
    Proc R Soc Med; 1965 Apr; 58(4):259-61. PubMed ID: 14263735
    [No Abstract]   [Full Text] [Related]  

  • 17. INTRAVASCULAR CLOTTING AND SPONTANEOUS FIBRINOLYSIS.
    KOLLER F
    Acta Haematol; 1964 Apr; 31():239-46. PubMed ID: 14169390
    [No Abstract]   [Full Text] [Related]  

  • 18. [DISSOCIATED EFFECTS OF A NEW ANTIFIBRINOLYTIC AGENT (EPSILON-AMINOCAPROIC ACID) INJECTED "IN VIVO", ON "IN VITRO" FIBRINOLYSIS TESTS].
    WEISS M; YVER J; SAMAMA M; DUBOST C
    Presse Med (1893); 1963 Sep; 71():1879-80. PubMed ID: 14091607
    [No Abstract]   [Full Text] [Related]  

  • 19. [EXPERIMENT WITH A PLASMIN PREPARATION BY USING THE CASIN SPLITTING TEST: THE ACTION OF PLASMIN-NOVO AND ITS INHIBITION WITH EPSILON-AMINOCAPROIC ACID AND TRASYLOL].
    BERGHOFF A; GLATZEL H
    Thromb Diath Haemorrh; 1964 Dec; 12():418-24. PubMed ID: 14254701
    [No Abstract]   [Full Text] [Related]  

  • 20. METHOD FOR DETERMINING EPSILON-AMINOCAPROIC ACID (EACA) IN BLOOD PLASMA, BASED ON THE ANTIFIBRINOLYTIC PROPERTIES OF THIS COMPOUND.
    WOLOSOWICZ N; NIEWIAROWSKI S; CZEREPKO K
    Thromb Diath Haemorrh; 1964 Jan; 10():309-16. PubMed ID: 14113373
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.